Physician profile
Mohamad Saab
NPI 1316258742
$1,795.66
in general payments reported to CMS, 2019-2025
15 companies · $21.47 in 2025
The $21.47 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,200 · 2020: $87.90 · 2021: $338 · 2022: $51.83 · 2023: $97.08 · 2025: $21.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $118.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ekos Corporation | $1,188.66 | 2019 | |
| Atricure, INC. | $197.34 | 2021 | |
| Angiodynamics, INC. | $115.62 | 2021-2023 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro |
| Janssen Pharmaceuticals, INC | $50.63 | 2020-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $43.96 | 2023 | Arcalyst |
| Cardiovascular Systems INC. | $40.90 | 2020-2022 | |
| Astellas Pharma US INC | $23.45 | 2020 | |
| Lundbeck LLC | $22.20 | 2020 | |
| Pfizer INC. | $21.47 | 2025 | |
| Medtronic, INC. | $20.42 | 2021 | |
| Preventice Services, LLC | $16.66 | 2021 | |
| Terumo Medical Corporation | $16.01 | 2020 | |
| Cardinal Health 200 LLC | $15.15 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.05 | 2020 | |
| Z-Medica, LLC | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamad Saab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.